Johnson & Johnson Vision Announces Series of Product Milestones and Launches Across Portfolio at American Academy of Ophthalmology 2017 Meeting

Source: Johnson & Johnson Vision

Johnson & Johnson Vision announced a series of product milestones and launches supporting its growing portfolio, designed to improve and restore sight for patients worldwide. These will be showcased during the American Academy of Ophthalmology (AAO) 2017 Meeting in New Orleans, November 11-14.

“The milestones and launches announced during AAO 2017 serve to underscore Johnson & Johnson Vision’s progress toward our aspiration to become a world leader in eye health,” Tom Frinzi, Worldwide President, Surgical Vision, Johnson & Johnson Vision, said in a company news release. “We are proud to provide eye care professionals with the tools and innovations to help millions of patients every year achieve their best possible vision and eye health.”

More than 350,000 TECNIS Symfony and Symfony Toric Lenses Implanted

As the first-ever extended depth of focus presbyopia correcting IOLs, TECNIS Symfony lenses are able to mitigate the effects of presbyopia while delivering high-contrast vision. By age 80, more than half of all Americans either have a cataract or have had cataract surgery.

CATALYS System Mobile Patient Bed Now Available

The new mobile bed ensures patients are comfortable from start-to-finish during cataract procedures, allowing them to relax in one, ergonomically-designed and adjustable bed, without needing to change positions or beds. Workflow is also optimized for physicians as the bed integrates simply and seamlessly with the CATALYS System through Bluetooth connectivity.

TearScience LipiScan and LipiFlow Now Available in Over 800 Offices

Now part of Johnson & Johnson Vision, TearScience LipiScan and LipiFlow technologies are now available in more than 800 optometrist and ophthalmologist offices in the U.S. and Canada. The news precedes the roll-out of a reduced pricing structure to enable more eye care professionals to access the latest technologies to rapidly image meibomian glands and treat meibomian gland dysfunction (MGD), a leading cause of dry eye. Dry eye affects more than 340 million people around the world and MGD is a leading cause of dry eye—found in 86% of dry eye patients.

iDESIGN System Now Approved by FDA for Expanded Indications

The iDESIGN System is now approved by the U.S. Food and Drug Administration for the following indications: myopia with and without astigmatism, hyperopia with and without astigmatism, and mixed astigmatism. The Company has also launched a new campaign, “When You Measure Better, You Treat Better,” to underscore the importance of a wavefront-guided treatment approach to support excellent patient results. A three-second scan with the iDESIGN System gathers over 1,200 micro readings, including information on the patient’s wavefront aberrometry, wavefront refraction, corneal topography, keratometry, and pupillometry. This data is then used to create a personalized LASIK treatment, which achieves 20/16 or better vision for the majority of myopic eyes.

Educational Opportunities of Note During AAO

Johnson & Johnson Vision is proud to demonstrate its commitment to equipping eye care professionals with the tools, knowledge and skills to deliver the best outcomes for patients.

The company is proud to announce a 3-year grant to the International Society of Refractive Surgery (ISRS), a partner of the AAO, to sponsor a new externship program. Though this initiative, surgeons can learn and work side-by-side with leading experts throughout Africa, Europe and the Middle East. More information is available at: https://isrs.aao.org/externships.

A number of educational activities will also be available at the Company’s booth (#125) and throughout the meeting. Onsite attendees can participate in demonstrations featuring the new CATALYS System Mobile Patient Bed, iDesign System, WHITESTAR SIGNATURE Pro Phacoemulsification System, and Tear Science’s LipiScan and LipiFlow technologies.

Assessing Vision Beyond Snellen Acuity: What Cataract Surgeons Need to Know About Optical Quality”

David Chang, MD, Tuesday, November 14, 9:00-10:00 AM, Room 397, Floor 3

This instructional course will provide a practical, non-mathematical understanding of how optical principles apply to patient care. At the conclusion, attendees will be able to describe the impact of optics on visual quality and the methods used to assess these indices in the clinical setting, as they relate to the TECNIS Family of IOLs.                    

“Advancements in Wavefront-Guided Technologies”

Saturday and Sunday, November 11-12, 1:00 PM and 2:00 PM, Booth #125

These two presentations will provide information on taking LASIK procedures to the next level.

“Phaco, Laser, and Ocular Surface Management Demonstrations”

Saturday and Sunday, November 11-12, 10:00 AM-4:00 PM, Booth #125

A variety of expert-led demonstrations will provide a chance for up-close learning.              

“Brilliance Bar”

Saturday and Sunday, November 11-12, 10:00 AM-4:00 PM, Booth #125

Individual sessions will be available with experts on surgical practice and procedures to ask questions and gain insights on the latest techniques and technologies. Reserve your timeslot at: boothprograms.jnjvisionsurgicaleducation.com.

Related Content